Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DBMM 34% gain Fri, on 4 million shares of volume. That has got to be extra-scary for naked shorts if we see a mega-short-squeeze develop!
$SPEYF Lithium Demand: Lithium is one of the most in-demand commodities across the globe given its immense use and benefits, especially in the battery market. According to a report by Deloitte, analysts have a consensus that the demand for lithium will double or even triple by 2030. It is predicted the global demand will reach over 1.79 million metric tonnes by 2030. Lithium is critical to meet the needs of an ever evolving renewable energy source. https://investorbrandmedia.com/speyf-ultimate-goal-of-putting-highly-prospective-properties-into-production/
$IJJP OTCMarket Profile page, good info: https://www.otcmarkets.com/stock/IJJP/profile
$HLRTF PR Highlights October 20, 2022...
*Hillcrest and Tier 1 automotive supplier sign memorandum of understanding to carry out joint development project for powertrain system
*Project to begin immediately and run through 2023
*Hillcrest inverter technology to underpin future product
$IJJP Our mission is to engage Major industry corporations with in-kind Social Responsibility Commitments to team with IJJCorp using eCETP.
$IJJP The Inflation Reduction Act of 2022 gives IJJ Corporation a significant boost that extends the period for funding its economic Impact Program.
https://www.nasdaq.com/press-release/the-inflation-reduction-act-of-2022-gives-ijj-corporation-a-significant-boost-that
$PVSP Pervasip owns 100% of Artizen Corporation (“Artizen Corp”). Artizen Corp’s wholly owned subsidiary, Zen Asset Management LLC (“ZAM”) is a foundational operator that provides the basis for our cannabis related investments. ZAM, a diversified asset management company was founded to acquire, develop, and support companies and technologies in the cannabis industry.
you still pushing this dog. its only a supply/demand play. your trying to pump and dump.
$PVSP Artizen On Instagram:
https://www.instagram.com/reel/CVRjKSOBw4c/
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets
https://www.pervasip.net/zen-asset-management-zam
$PVSP 24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP Pervasip owns 100% of Artizen Corporation (“Artizen Corp”). Artizen Corp’s wholly owned subsidiary, Zen Asset Management LLC (“ZAM”) is a foundational operator that provides the basis for our cannabis related investments. ZAM, a diversified asset management company was founded to acquire, develop, and support companies and technologies in the cannabis industry.
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$PVSP Pervasip owns 100% of Artizen Corporation (“Artizen Corp”). Artizen Corp’s wholly owned subsidiary, Zen Asset Management LLC (“ZAM”) is a foundational operator that provides the basis for our cannabis related investments. ZAM, a diversified asset management company was founded to acquire, develop, and support companies and technologies in the cannabis industry.
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$PVSP 24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$PVSP Pervasip Announces $1.6 Million in August Revenues and 3rd Quarter Guidance
https://finance.yahoo.com/news/pervasip-announces-1-6-million-131500755.html
$PVSP we are Artizen cannabis and we are expanding rapidly nationwide and international markets too!
$PVSP Twitter status update: https://twitter.com/PervasipC
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$IVDN - For Hurricane Ian Rebuilding Effort...
Patented House Wrap Insulation with Thermal Energy Saving Far Beyond Competition Gaining Recognition as Company Wins Court Case & 260K Cash Settlement: Innovative Designs, Inc.
Click here:
https://www.digitaljournal.com/pr/patented-house-wrap-insulation-with-thermal-energy-saving-far-beyond-competition-gaining-recognition-as-company-wins-court-case-260k-cash-settlement-innovative-designs-inc-otcqb-ivdn#ixzz7eEHyv3uY
Company website:
http://www.insultexhousewrap.com
$TORVF in a NutShell:
1. Next Generation Lithium Battery Tech (Solid State).
2. Novel Graphite Mining Separation Tech.
3. Producing batteries for specialized applications.
4. Owns 3 Graphite Mines.
5. Owns Rare-Earth Metal Mines
6. Company is run by PhD's
7. Zero Conv Debt.
8. All financing by management personal checks, private placements, options, warrants.
Z
FYI-- checked on FLEX-(Jake)- the hurricane missed him!
$PVSP 24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP DESCRIPTION
We provide business consulting and marketing services to public companies. More than 100 companies have purchased space on our website https://privateequitymarkets.us/. Our website features publicly traded companies and highlights the mining, technology, bio-tech, green-tech and cannabis industries. Services include free listings of press releases and a news feed.
$PVSP Recognizing the need for consistency, quality and the opportunity to reach customers across state borders, Artizen was spun off into a brand asset and licensed to independent cultivators in Washington State. The brand’s responsibility to its customers required implementation of grow SOPs, genetic road-mapping, branding assets, and various tools needed in support of marketing and selling Artizen™ branded products.
$PVSP reports that various new product lines and planned near-term acquisitions will add revenue, new growth opportunities, and be a springboard for expansion into other recreational cannabis markets in the US.
$SWISF Sekur Private Data Surpasses 2022 Users Target - Sees No Recession in Sight for its Sekur Privacy Communications Solutions
https://www.stocktitan.net/news/SWISF/sekur-private-data-surpasses-2022-users-target-sees-no-recession-in-uvknk1jqb3km.html
$HWAL..Price spike coming?>>>>>http://www.wallstreetresearcher.com
$PVSP Pervasip owns 100% of Artizen Corporation (“Artizen Corp”). Artizen Corp’s wholly owned subsidiary, Zen Asset Management LLC (“ZAM”) is a foundational operator that provides the basis for our cannabis related investments. ZAM, a diversified asset management company was founded to acquire, develop, and support companies and technologies in the cannabis industry.
FTEG: 0.0001
52w: 0.0001 - 0.0012
Outstanding Shares 08/12/2022
37,303,174,194
= market cap: 3.73 million
Float??
1,651,492,193
03/14/2019
Total shares outstanding: 4,841,492,193 as of date: December 31, 2020
Public Float: 1,651,492,193 as of date: December 31, 2020
"Integrity Health’s mission is to disrupt the normalcy of traditional western medicine by making patients more aware they can achieve a healthier, pain-free, longer life through the highest quality products and services designed and dispensed by Integrity Health professionals!"
Employees : 12
https://www.integrityhealthcorp.com/
Apr 28 2022 0.0002
Nov 22 2021 0.0003
Oct 22 2021 0.0004
Jul 16 2021 0.0005
Jul 02 2021 0.0006
Jun 22 2021 0.0007
Jun 07 2021 0.0008
...
Apr 12 2021 0.0032
As of 03/31/2021, the number of shares outstanding of our Common Stock was:
13,912,980,953
= market cap: 44.5 million
CRSM: 0.0038
52w: 0.0028 - 0.0543
https://twitter.com/HedgehogTrader/status/1536768322460581890/photo/1
https://smarttholdings.com/
https://twitter.com/car_smartt/status/1517542931376349184?cxt=HHwWgIC9wa_Qso8qAAAAOur%20share%20structure%20has%20remained%20the%20same%20since%20last%20year.As%20of%2008/30/2021,%20the%20number%20of%20shares%20outstanding%20of%20our%20Common%20Stock%20was:595,304,566
https://blackbrickconstruction.com/
In June, we acquired Black Brick Construction, which specializes in ground up construction. The company has over $100K in positive cash flow and three new projects with potential for more growth.
https://smarttholdings.com/#
https://smarttholdings.com/real-estate/
https://smarttholdings.com/projects/
no dilution
07/09 : 595,304,566 shares Float 175,117,101
As of 03/31/2022, the number of shares outstanding of our Common Stock was:
596,304,566
As of 12/31/2021, the number of shares outstanding of our Common Stock was:
596,304,566
As of 09/30/2021, the number of shares outstanding of our Common Stock was:
596,304,566
no dilution so room for a big rebound
Feb 23, 2022 0.0060
Jan 19, 2022 0.0084
Oct 25, 2021 0.0120
Sep 27, 2021 0.0169
Aug 23, 2021 0.0290
Jul 26, 2021 0.0550
Smartt, Inc., through its subsidiaries, engages in the technology, construction, real estate, and import/export businesses in the United States. The company undertakes commercial and residential projects; and provides repair/restoration services. It is also involved in the Fintech, crypto, blockchain, and software businesses. The company was formerly known as CarSmartt, Inc. and changed its name to Smartt, Inc. in May 2021. Smartt, Inc. was founded in 2007 and is headquartered in Coral Gables, Florida.
Total Assets $ 2,057,277
Total Current Liabilities $ 108,805
= $ 1.948.472
CRSM:
They made a profit of 111,902 in first 3 months 2022
111.902 x 4 = 447.608/ year
p/e 20 = $ 8.952.160
$ 8.952.160 : 596,304,566 shares = $0.0150 / share
= 3 times the current share price.
$PVSP Pervasip Corp. (PVSP) is a developer of companies and technologies in high value emerging markets with a focus on cannabis and the medical use of fungi and psychedelics
$PVSP Pervasip owns 100% of Artizen Corporation (“Artizen Corp”). Artizen Corp’s wholly owned subsidiary, Zen Asset Management LLC (“ZAM”) is a foundational operator that provides the basis for our cannabis related investments. ZAM, a diversified asset management company was founded to acquire, develop, and support companies and technologies in the cannabis industry.
$PVSP we are Artizen cannabis and we are expanding rapidly nationwide and international markets too!
says we are a top 19 producer in the #USA come see what we do online
$GMPR - Update on major developments taking place right now with full company press releases coming up later this week ...
Gourmet Provisions International@GourmetProvInt·
We are signing the Blackrock Acquisition Agreement today & anticipate getting signed copy back by tmrw! We will PR with full details this week. PR will recap financials, BR deal & full list of timelines. Separate press on many new store locations for pizza, salsa & Military $GMPR
Twitter Link:
https://twitter.com/search?q=%24GMPR&src=typeahead_click
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$PVSP reports that various new product lines and planned near-term acquisitions will add revenue, new growth opportunities, and be a springboard for expansion into other recreational cannabis markets in the US.
$PVSP Pervasip owns 100% of Artizen Corporation (“Artizen Corp”). Artizen Corp’s wholly owned subsidiary, Zen Asset Management LLC (“ZAM”) is a foundational operator that provides the basis for our cannabis related investments. ZAM, a diversified asset management company was founded to acquire, develop, and support companies and technologies in the cannabis industry.
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$PVSP Intereactive Chart https://www.barchart.com/stocks/quotes/PVSP/interactive-chart
$PVSP Pervasip owns 100% of Artizen Corporation (“Artizen Corp”). Artizen Corp’s wholly owned subsidiary, Zen Asset Management LLC (“ZAM”) is a foundational operator that provides the basis for our cannabis related investments. ZAM, a diversified asset management company was founded to acquire, develop, and support companies and technologies in the cannabis industry.
81% of Regencell Bioscience Holdings Limited (NASDAQ: $RGC) is owned by insiders, and they've been buying recently https://finance.yahoo.com/news/81-regencell-bioscience-holdings-limited-105517095.html
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
1. History repeats itself.
2. People drive buying and selling.
3. Buy at support, sell at resistance. Everyone sees the same thing and they're all just waiting to jump in the pool.
4. Short rallies not selloffs. When markets drop, shorts finally turn a profit and get ready to cover.
5. Don't buy up into a major moving average or sell down into one. See #3.
6. Don't chase momentum if you can't find the exit. Assume the market will reverse the minute you get in. If it's a long way to the door, you're in big trouble.
7. Exhaustion gaps get filled. Breakaway and continuation gaps don't. The old traders' wisdom is a lie. Trade in the direction of gap support whenever you can.
8. Trends test the point of last support/resistance. Enter here even if it hurts.
9. Trade with the TICK not against it. Don't be a hero. Go with the money flow.
10. If you have to look, it isn't there. Forget your college degree and trust your instincts.
11. Sell the second high, buy the second low. After sharp pullbacks, the first test of any high or low always runs into resistance. Look for the break on the third or fourth try.
12. The trend is your friend in the last hour. As volume cranks up at 3:00pm don't expect anyone to change the channel.
13. Avoid the open. They see YOU coming sucker 1-2-3-Drop-Up.
14. Look for downtrends to reverse after a top, two lower highs and a double bottom.
15. Bulls live above the 200 day, bears live below. Sellers eat up rallies below this key moving average line and buyers to come to the rescue above it.
16. Price has memory. What did price do the last time it hit a certain level? Chances are it will do it again.
17. Big volume kills moves. Climax blow-offs take both buyers and sellers out of the market and lead to sideways action.
18. Trends never turn on a dime. Reversals build slowly. The first sharp dip always finds buyers and the first sharp rise always finds sellers.
19. Bottoms take longer to form than tops. Fear acts more quickly than greed and causes stocks to drop from their own weight.
20. Beat the crowd in and out the door. You have to take their money before they take yours, period.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |